Keynote address: Multidrug resistance: A pleiotropic response to cytotoxic drugs

Craig R. Fairchild, Kenneth H. Cowan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Tumor cells exposed in tissue culture to one of several different classes of antineoplastic agents, including anthracyclines, vinca alkaloids, epipodophyllotoxins, and certain antitumor antibiotics, can develop resistance to the selecting agent and cross resistance to the other classes of agents. This phenomena of multidrug resistance is generally associated with decreased drug accumulation and overexpression of a membrane glycoprotein. This membrane protein, referred to as P-glycoprotein, apparently acts as an energy-dependent drug efflux pump. Multidrug resistance in human MCF-7 breast cancer cells selected for resistance to adriamycin (AdrR MCF-7) is associated with amplification and overexpression of the mdrl gene which encodes P-glycoprotein. A number of other changes are also seen in this resistant cell line including alterations in Phase I and Phase II drug metabolizing enzymes. Similar biochemical changes occur in a rat model for hepatocellular carcinogenesis and are associated in that system with broad spectrum resistance to hepatotoxins. The similar changes in these two models of resistance suggests that these changes might be part of a battery of genes whose expression can be altered in response to cytotoxic stress, thus rendering the cell resistant to a wide variety of cytotoxic agents.

Original languageEnglish (US)
Pages (from-to)361-367
Number of pages7
JournalInternational Journal of Radiation Oncology, Biology, Physics
Volume20
Issue number2
DOIs
StatePublished - Feb 1991

Fingerprint

Multiple Drug Resistance
drugs
P-Glycoprotein
Pharmaceutical Preparations
Podophyllotoxin
Vinca Alkaloids
Anthracyclines
Membrane Glycoproteins
Cytotoxins
Antineoplastic Agents
Doxorubicin
Membrane Proteins
Carcinogenesis
Breast Neoplasms
Anti-Bacterial Agents
Gene Expression
Cell Line
membranes
efflux
Enzymes

Keywords

  • Glutathione S-transferase
  • Hyperoplastic liver nodules
  • Multidrug resistance
  • P-glycoprotein
  • Xenobiotic resistance

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Keynote address : Multidrug resistance: A pleiotropic response to cytotoxic drugs. / Fairchild, Craig R.; Cowan, Kenneth H.

In: International Journal of Radiation Oncology, Biology, Physics, Vol. 20, No. 2, 02.1991, p. 361-367.

Research output: Contribution to journalArticle

@article{1ca3677b641b4a76af23a36b5f59068f,
title = "Keynote address: Multidrug resistance: A pleiotropic response to cytotoxic drugs",
abstract = "Tumor cells exposed in tissue culture to one of several different classes of antineoplastic agents, including anthracyclines, vinca alkaloids, epipodophyllotoxins, and certain antitumor antibiotics, can develop resistance to the selecting agent and cross resistance to the other classes of agents. This phenomena of multidrug resistance is generally associated with decreased drug accumulation and overexpression of a membrane glycoprotein. This membrane protein, referred to as P-glycoprotein, apparently acts as an energy-dependent drug efflux pump. Multidrug resistance in human MCF-7 breast cancer cells selected for resistance to adriamycin (AdrR MCF-7) is associated with amplification and overexpression of the mdrl gene which encodes P-glycoprotein. A number of other changes are also seen in this resistant cell line including alterations in Phase I and Phase II drug metabolizing enzymes. Similar biochemical changes occur in a rat model for hepatocellular carcinogenesis and are associated in that system with broad spectrum resistance to hepatotoxins. The similar changes in these two models of resistance suggests that these changes might be part of a battery of genes whose expression can be altered in response to cytotoxic stress, thus rendering the cell resistant to a wide variety of cytotoxic agents.",
keywords = "Glutathione S-transferase, Hyperoplastic liver nodules, Multidrug resistance, P-glycoprotein, Xenobiotic resistance",
author = "Fairchild, {Craig R.} and Cowan, {Kenneth H.}",
year = "1991",
month = "2",
doi = "10.1016/0360-3016(91)90121-J",
language = "English (US)",
volume = "20",
pages = "361--367",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Keynote address

T2 - Multidrug resistance: A pleiotropic response to cytotoxic drugs

AU - Fairchild, Craig R.

AU - Cowan, Kenneth H.

PY - 1991/2

Y1 - 1991/2

N2 - Tumor cells exposed in tissue culture to one of several different classes of antineoplastic agents, including anthracyclines, vinca alkaloids, epipodophyllotoxins, and certain antitumor antibiotics, can develop resistance to the selecting agent and cross resistance to the other classes of agents. This phenomena of multidrug resistance is generally associated with decreased drug accumulation and overexpression of a membrane glycoprotein. This membrane protein, referred to as P-glycoprotein, apparently acts as an energy-dependent drug efflux pump. Multidrug resistance in human MCF-7 breast cancer cells selected for resistance to adriamycin (AdrR MCF-7) is associated with amplification and overexpression of the mdrl gene which encodes P-glycoprotein. A number of other changes are also seen in this resistant cell line including alterations in Phase I and Phase II drug metabolizing enzymes. Similar biochemical changes occur in a rat model for hepatocellular carcinogenesis and are associated in that system with broad spectrum resistance to hepatotoxins. The similar changes in these two models of resistance suggests that these changes might be part of a battery of genes whose expression can be altered in response to cytotoxic stress, thus rendering the cell resistant to a wide variety of cytotoxic agents.

AB - Tumor cells exposed in tissue culture to one of several different classes of antineoplastic agents, including anthracyclines, vinca alkaloids, epipodophyllotoxins, and certain antitumor antibiotics, can develop resistance to the selecting agent and cross resistance to the other classes of agents. This phenomena of multidrug resistance is generally associated with decreased drug accumulation and overexpression of a membrane glycoprotein. This membrane protein, referred to as P-glycoprotein, apparently acts as an energy-dependent drug efflux pump. Multidrug resistance in human MCF-7 breast cancer cells selected for resistance to adriamycin (AdrR MCF-7) is associated with amplification and overexpression of the mdrl gene which encodes P-glycoprotein. A number of other changes are also seen in this resistant cell line including alterations in Phase I and Phase II drug metabolizing enzymes. Similar biochemical changes occur in a rat model for hepatocellular carcinogenesis and are associated in that system with broad spectrum resistance to hepatotoxins. The similar changes in these two models of resistance suggests that these changes might be part of a battery of genes whose expression can be altered in response to cytotoxic stress, thus rendering the cell resistant to a wide variety of cytotoxic agents.

KW - Glutathione S-transferase

KW - Hyperoplastic liver nodules

KW - Multidrug resistance

KW - P-glycoprotein

KW - Xenobiotic resistance

UR - http://www.scopus.com/inward/record.url?scp=0025969742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025969742&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(91)90121-J

DO - 10.1016/0360-3016(91)90121-J

M3 - Article

C2 - 1671383

AN - SCOPUS:0025969742

VL - 20

SP - 361

EP - 367

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -